About J. Craig Venter Institute
Pioneering Infectious Disease Research to Positively Impact Life
The J. Craig Venter Institute (JCVI) is a world leader in infectious disease research with 160 scientists and staff who are bold innovators fearlessly pursuing revolutionary ideas. With a long track-record of creativity and an interdisciplinary approach to genomics, JCVI is committed to accelerating foundational scientific research to drive advances in infectious diseases.
Globally, human lifespans have been increasing in large part due to advances in treating and eliminating infectious diseases. Yet, the threat from emerging, reemerging and entrenched infectious diseases remains a challenge for society. Traditional methodology has had success in the past, but with an ever-globalizing world, the need for fast, accurate and comprehensive research is paramount. Partnering with international collaborators is enabling JCVI to be the catalyst for better understanding and potential new treatments against the scourge of infectious disease.
This is just one of the many research areas our team is tackling as we seek to make a worldwide impact with our science.
Human
Health
+
Environment
+Synthetic
Biology
+
JCVI researchers continue their legacy of success with countless new breakthroughs: the first synthetic cell, the first diploid human genome, discovery of more than 60 million new genes from the Sorcerer II Global Expedition, seminal work in cataloguing the human microbiome (all the microbes that live in and on the human body) and important research into a variety of infectious diseases and antibiotic resistance. These are just a few of the many research areas our team is tackling as we seek to make a worldwide impact with our science.
J. Craig Venter Institute is registered as a 501(c)(3) nonprofit organization. Contributions to J. Craig Venter Institute are tax-deductible to the extent permitted by law. J. Craig Venter Institute’s tax identification number is 52-1842938.